The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
"Herd Immunity": A Rough Guide
Abstract
The term "herd immunity" is widely used but carries a variety of meanings. Some authors use it to describe the proportion immune among individuals in a population. Others use it with reference to a particular threshold proportion of immune individuals that should lead to a decline in incidence of infection. Still others use it to refer to a pattern of immunity that should protect a population from invasion of a new infection. A common implication of the term is that the risk of infection among susceptible individuals in a population is reduced by the presence and proximity of immune individuals (this is sometimes referred to as "indirect protection" or a "herd effect"). We provide brief historical, epidemiologic, theoretical, and pragmatic public health perspectives on this concept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
Mossong, J., Hens, N., Jit, M., Beutels, P., Auranen, K., Mikolajczyk, R., Massari, M., Salmaso, S., Tomba, G. S., Wallinga, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050074 · Cited by 2,900
Modeling Infectious Diseases in Humans and Animals
Keeling, M. J., & Rohani, P. (2011) · Princeton University Press eBooks · doi:10.2307/j.ctvcm4gk0 · Cited by 2,688
Keeling, M. J., & Eames, K. T. D. (2005) · Journal of The Royal Society Interface · doi:10.1098/rsif.2005.0051 · Cited by 1,876
Self-citationControl of Communicable Diseases Manual
(2015) · American Public Health Association eBooks · doi:10.2105/ccdm.2745 · Cited by 1,599
The Epidemiology and Control of Malaria
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb105313.x · Cited by 1,255
Colizza, V., Barrat, A., Barthélemy, M., & Vespignani, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510525103 · Cited by 1,155
Herd Immunity: History, Theory, Practice
Fine, P. E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 905
Self-citationThe Japanese Experience with Vaccinating Schoolchildren against Influenza
Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., & Tashiro, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441204 · Cited by 861
Vaccination and the theory of games
Bauch, C. T., & Earn, D. J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403823101 · Cited by 844
Cited by
Vaccine hesitancy: An overview
Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24657 · Cited by 2,172
Haas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564
Functional Fear Predicts Public Health Compliance in the COVID-19 Pandemic
Harper, C. A., Satchell, L. P., Fido, D., & Latzman, R. D. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00281-5 · Cited by 1,564
Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., & Böhm, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208601 · Cited by 1,282
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults
Fisher, K. A., Bloomstone, S. J., Walder, J., Crawford, S., Fouayzi, H., & Mazor, K. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3569 · Cited by 1,189
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Neumann-Böhme, S., Varghese, N. E., Sabat, I., Barros, P. P., Brouwer, W., van Exel, J., Schreyögg, J., & Stargardt, T. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01208-6 · Cited by 1,011
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
Dubé, E., Vivion, M., & MacDonald, N. E. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.964212 · Cited by 986
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Choy, K.-T., Wong, A. Y.-L., Kaewpreedee, P., Sia, S. F., Chen, D., Hui, K. P. Y., Chu, D. K. W., Chan, M. C. W., Cheung, P. P.-H., Huang, X., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104786 · Cited by 922
Modeling COVID-19 scenarios for the United States
IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1132-9 · Cited by 556
Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan
El-Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al-Sawalha, N. A., & Alali, F. Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250555 · Cited by 551
Buss, L. F., Prete, C. A., Abrahim, C. M. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., França, R. F. O., Belotti, M. C., Carvalho, M. P. S. S., Costa, A. G., et al. (2021) · Science · doi:10.1126/science.abe9728 · Cited by 488
Flattening the COVID-19 peak: Containment and mitigation policies
(2020) · OECD Policy Responses to Coronavirus (COVID-19) · doi:10.1787/e96a4226-en · Cited by 452
The Anti-vaccination Movement: A Regression in Modern Medicine
Hussain, A., Ali, S., Ahmed, M., & Hussain, S. (2018) · Cureus · doi:10.7759/cureus.2919 · Cited by 416
Using behavioral insights to increase vaccination policy effectiveness
Betsch, C., Böhm, R., & Chapman, G. B. (2015) · Policy Insights from the Behavioral and Brain Sciences · doi:10.1177/2372732215600716 · Cited by 378
The influence of political ideology and trust on willingness to vaccinate
Baumgaertner, B., Carlisle, J. E., & Justwan, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191728 · Cited by 359
Lindholt, M. F., Jørgensen, F., Bor, A., & Petersen, M. B. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048172 · Cited by 331
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
Gomes, M. G. M., Ferreira, M. U., Corder, R. M., King, J. G., Souto-Maior, C., Penha-Gonçalves, C., Gonçalves, G., Chikina, M., Pegden, W., & Aguas, R. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111063 · Cited by 329
On the benefits of explaining herd immunity in vaccine advocacy
Betsch, C., Böhm, R., Korn, L., & Holtmann, C. (2017) · Nature Human Behaviour · doi:10.1038/s41562-017-0056 · Cited by 325
Trust in science, social consensus and vaccine confidence
Sturgis, P., Brunton-Smith, I., & Jackson, J. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01115-7 · Cited by 323
The Role of Antibody Testing for SARS-CoV-2: Is There One?
Theel, E. S., Slev, P., Wheeler, S., Couturier, M. R., Wong, S. J., & Kadkhoda, K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00797-20 · Cited by 305
Taylor, S., Landry, C. A., Paluszek, M. M., Groenewoud, R., Rachor, G. S., & Asmundson, G. J. G. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.575950 · Cited by 282
Vaccine Hesitancy: Contemporary Issues and Historical Background
Nuwarda, R. F., Ramzan, I., Weekes, L., & Kayser, V. (2022) · Vaccines · doi:10.3390/vaccines10101595 · Cited by 282
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Machida, M., Nakamura, I., Kojima, T., Saito, R., Nakaya, T., Hanibuchi, T., Takamiya, T., Odagiri, Y., Fukushima, N., Kikuchi, H., et al. (2021) · Vaccines · doi:10.3390/vaccines9030210 · Cited by 281
Vaccine impact: Benefits for human health
Doherty, M., Buchy, P., Standaert, B., Giaquinto, C., & Prado- Cohrs, D. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.025 · Cited by 272
Effectiveness of meningococcal serogroup C vaccine programmes
Borrow, R., Abad, R., Trotter, C., van der Klis, F. R. M., & Vazquez, J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.083 · Cited by 88
Herd immunity by infection is not an option
Sridhar, D., & Gurdasani, D. (2021) · Science · doi:10.1126/science.abf7921 · Cited by 60
Metadata
- Authors
- Fine, P., Eames, K., & Heymann, D. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-22
- Volume
- 52
- Issue
- 7
- Pages
- 911-916
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2130878567
- Cited by
- 1,247
- References
- 29
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.